0001213900-16-014382.txt : 20160620 0001213900-16-014382.hdr.sgml : 20160620 20160620171028 ACCESSION NUMBER: 0001213900-16-014382 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160616 FILED AS OF DATE: 20160620 DATE AS OF CHANGE: 20160620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZELDIS JEROME B CENTRAL INDEX KEY: 0001433982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 161722783 MAIL ADDRESS: STREET 1: 8767 E. VIA DE VENTURA, SUITE 190 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 4 1 f4061616zeldis_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2016-06-16 0 0000812796 SOLIGENIX, INC. SNGX 0001433982 ZELDIS JEROME B 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 1 0 0 0 Stock Option (Right to Buy) 0.74 2016-06-16 4 A 0 40541 0 A 2026-06-15 Common Stock 40541 40541 D The stock option vests ratably on each of September 16, 2016, December 16, 2016, March 16, 2017 and June 16, 2017. /s/ Jerome B. Zeldis 2016-06-20